Rights and permissions
About this article
Cite this article
Drotrecogin alfa “cost effective option” in severe sepsis in the UK. Inpharma Wkly. 1485, 5 (2005). https://doi.org/10.2165/00128413-200514850-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514850-00012